Market Closed -
Nasdaq
21:00:00 10/05/2024 BST
5-day change
1st Jan Change
19.54
USD
+8.50%
+8.37%
+20.25%
Presentation Operator MessageOperator (Operator)Good afternoon, ladies and gentlemen, and than...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Earnings Flash (BLFS) BIOLIFE SOLUTIONS Posts Q1 Revenue $31.7M, vs. Street Est of $24.9M
05-09
MT
Transcript : BioLife Solutions, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09
BioLife Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-09
CI
BioLife Solutions Completes Divestment of Global Cooling Subsidiary
04-18
MT
An undisclosed buyer entered into a Stock Purchase Agreement to acquire Global Cooling, Inc. from BioLife Solutions, Inc. for $2.6 million.
04-17
CI
Jefferies Initiates Coverage on BioLife Solutions With Buy Rating, $22 Price Target
04-04
MT
BioLife Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
02-29
CI
Transcript : BioLife Solutions, Inc., Q4 2023 Earnings Call, Feb 29, 2024
02-29
BioLife Solutions, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
02-29
CI
Biolife Solutions Announces Preliminary Unaudited Revenue Results for Fourth Quarter and Full Year 2023
01-08
CI
Lake Street Adjusts BioLife Solutions Price Target to $15 From $25, Maintains Buy Rating
11-10
MT
Transcript : BioLife Solutions, Inc., Q3 2023 Earnings Call, Nov 09, 2023
11-09
BioLife Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-09
CI
Casdin Capital Engages in Discussions with BioLife Solutions
24/10/23
CI
BioLife Solutions Names New CEO; Sees 2023 Revenue at Low End of Guidance
19/10/23
MT
BioLife Solutions, Inc. Announces Chief Executive Officer Changes
19/10/23
CI
BioLife Solutions, Inc. Announces Management Changes
19/10/23
CI
BioLife Solutions, Inc. Revises Earnings Guidance for the Full Year 2023
19/10/23
CI
BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC
18/10/23
CI
Lake Street Adjusts Price Target on BioLife Solutions to $25 From $34, Maintains Buy Rating
09/08/23
MT
Transcript : BioLife Solutions, Inc., Q2 2023 Earnings Call, Aug 08, 2023
08/08/23
Biolife Solutions, Inc. Provides Earnings Guidance for the Year 2023
08/08/23
CI
BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
08/08/23
CI
Stephens Adjusts BioLife Solutions Price Target to $29 From $27, Maintains Overweight Rating
17/07/23
MT
Craig-Hallum Starts BioLife Solutions at Buy With $29 Price Target
11/07/23
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.
More about the company
Last Close Price
19.54
USD
Average target price
23.43
USD
Spread / Average Target
+19.90%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1